Variant report

Variant	rs10817602
Chromosome Location	chr9:117160921-117160922
allele	A/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	POLR2A	chr9:117160421-117160923	Hela-S3	cervix:	n/a	n/a
2	POLR2A	chr9:117160894-117161032	A549	lung:	n/a	n/a
3	E2F6	chr9:117160349-117161024	H1-hESC	embryonic stem cell:	n/a	chr9:117160908-117160917 chr9:117160626-117160637
4	YY1	chr9:117160542-117161062	K562	blood:	n/a	chr9:117160895-117160909 chr9:117160895-117160904
5	MAX	chr9:117159125-117160977	K562	blood:	n/a	chr9:117159366-117159376 chr9:117159335-117159344 chr9:117159413-117159422
6	HEY1	chr9:117160865-117161045	K562	blood:	n/a	n/a
7	POLR2A	chr9:117159626-117161210	GM12892	blood:	n/a	n/a
8	SMARCB1	chr9:117159574-117161079	Hela-S3	cervix:	n/a	n/a
9	CEBPB	chr9:117160476-117161341	HepG2	liver:	n/a	chr9:117160810-117160821
10	POLR2A	chr9:117160160-117161168	K562	blood:	n/a	n/a
11	CREB1	chr9:117160418-117160939	A549	lung:	n/a	n/a
12	YY1	chr9:117160665-117161187	HepG2	liver:	n/a	chr9:117160895-117160909 chr9:117160895-117160904
13	REST	chr9:117160366-117160928	ECC-1	luminal epithelium:	n/a	chr9:117160375-117160388 chr9:117160616-117160625
14	SP1	chr9:117159909-117161081	GM12878	blood:	n/a	chr9:117160790-117160799 chr9:117160358-117160370 chr9:117160295-117160305 chr9:117160358-117160370 chr9:117160702-117160711 chr9:117160789-117160801 chr9:117160360-117160369 chr9:117160907-117160916 chr9:117160791-117160800 chr9:117160701-117160710 chr9:117160791-117160800 chr9:117160789-117160801 chr9:117160789-117160800 chr9:117160906-117160918 chr9:117160857-117160868 chr9:117160700-117160712 chr9:117160908-117160917 chr9:117160786-117160800 chr9:117160906-117160918
15	RCOR1	chr9:117159317-117161171	K562	blood:	n/a	n/a
16	MAX	chr9:117159934-117160940	GM12878	blood:	n/a	n/a
17	POLR2A	chr9:117159817-117161005	GM12878	blood:	n/a	n/a
18	POLR2A	chr9:117160460-117161169	HCT-116	colon:	n/a	n/a
19	HEY1	chr9:117160857-117161084	HepG2	liver:	n/a	n/a
20	TBP	chr9:117160551-117161061	HepG2	liver:	n/a	n/a
21	CEBPB	chr9:117160492-117161213	MCF-7	breast:	n/a	chr9:117160810-117160821
22	NFYB	chr9:117160462-117161030	Hela-S3	cervix:	n/a	chr9:117160874-117160889
23	POLR2A	chr9:117160330-117161125	HCT-116	colon:	n/a	n/a
24	POLR2A	chr9:117159714-117161176	GM15510	blood:	n/a	n/a
25	MAX	chr9:117159328-117161172	ECC-1	luminal epithelium:	n/a	chr9:117159366-117159376 chr9:117159335-117159344 chr9:117159413-117159422
26	MAX	chr9:117160360-117160947	H1-hESC	embryonic stem cell:	n/a	n/a
27	MAX	chr9:117160296-117161063	K562	blood:	n/a	n/a
28	POU2F2	chr9:117159729-117161097	GM12878	blood:	n/a	chr9:117160808-117160819 chr9:117160806-117160819 chr9:117160806-117160820 chr9:117160807-117160817 chr9:117160806-117160818
29	TAF1	chr9:117160812-117161081	H1-hESC	embryonic stem cell:	n/a	n/a
30	MAX	chr9:117159649-117160994	ECC-1	luminal epithelium:	n/a	n/a
31	E2F6	chr9:117160438-117161148	A549	lung:	n/a	chr9:117160908-117160917 chr9:117160626-117160637
32	ELF1	chr9:117160576-117161068	HepG2	liver:	n/a	chr9:117160897-117160909
33	POLR2A	chr9:117160878-117161076	GM12878	blood:	n/a	n/a
34	CEBPB	chr9:117160634-117161324	K562	blood:	n/a	chr9:117160810-117160821
35	E2F6	chr9:117160324-117161101	A549	lung:	n/a	chr9:117160908-117160917 chr9:117160626-117160637
36	TCF12	chr9:117160153-117160963	ECC-1	luminal epithelium:	n/a	n/a
37	MAZ	chr9:117159464-117161063	GM12878	blood:	n/a	n/a
38	CCNT2	chr9:117160008-117161026	K562	blood:	n/a	chr9:117160360-117160369
39	TCF7L2	chr9:117160885-117161010	Hela-S3	cervix:	n/a	n/a
40	MAX	chr9:117160223-117161013	A549	lung:	n/a	n/a
41	POLR2A	chr9:117160851-117161098	H1-hESC	embryonic stem cell:	n/a	n/a
42	POLR2A	chr9:117160874-117161281	H1-hESC	embryonic stem cell:	n/a	n/a
43	MAX	chr9:117160370-117160975	Hela-S3	cervix:	n/a	n/a
44	UBTF	chr9:117159795-117161051	K562	blood:	n/a	n/a
45	MAX	chr9:117159939-117161238	A549	lung:	n/a	n/a
46	POLR2A	chr9:117159091-117161169	K562	blood:	n/a	n/a
47	SP4	chr9:117160522-117161050	H1-hESC	embryonic stem cell:	n/a	chr9:117160789-117160800 chr9:117160857-117160868
48	RFX5	chr9:117159706-117160999	GM12878	blood:	n/a	chr9:117160275-117160292 chr9:117160276-117160291 chr9:117160276-117160291
49	POLR2A	chr9:117160444-117161084	Hela-S3	cervix:	n/a	n/a
50	POLR2A	chr9:117159762-117161170	GM12892	blood:	n/a	n/a

No.	Distal block	Cell Line	Cell type
1	chr9:117159319..117161244-chr9:117264260..117266190,2	MCF-7	breast:
2	chr9:117108355..117112346-chr9:117155430..117161997,5	MCF-7	breast:
3	chr9:117136553..117139395-chr9:117157861..117162089,3	K562	blood:
4	chr6:159238886..159239703-chr9:117160766..117161306,2	HCT-116	colon:
5	chr9:117155204..117158702-chr9:117159212..117161849,5	MCF-7	breast:
6	chr16:87984500..87985348-chr9:117160629..117161483,2	Hela-S3	cervix:
7	chr9:117160090..117161808-chr9:117267255..117268992,2	MCF-7	breast:
8	chr9:117157540..117162429-chr9:117265948..117270229,5	K562	blood:
9	chr9:117148465..117156866-chr9:117157996..117162015,11	K562	blood:

Variant related genes	Relation type
ENSG00000235119	TF binding region
AKNA	TF binding region
ENSG00000233893	Chromatin interaction
ENSG00000095397	Chromatin interaction
ENSG00000106948	Chromatin interaction
ENSG00000172530	Chromatin interaction
ENSG00000092820	Chromatin interaction

Extended variants
information (count: 75 )
Associated
traits (count: 3 )

rSNPs within LD-proxies of this variant (count:41)

rs_ID	r²[population]
rs10081697	0.85[CHB][hapmap];0.95[JPT][hapmap]
rs10739409	1.00[YRI][hapmap]
rs10739411	0.85[CHB][hapmap];0.80[CHD][hapmap];0.95[JPT][hapmap];0.81[ASN][1000 genomes]
rs10739412	0.85[CHB][hapmap];0.80[CHD][hapmap];0.95[JPT][hapmap]
rs10759694	1.00[ASW][hapmap];0.95[CEU][hapmap];1.00[CHB][hapmap];1.00[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];1.00[LWK][hapmap];1.00[MEX][hapmap];1.00[MKK][hapmap];1.00[TSI][hapmap];0.95[AMR][1000 genomes];1.00[EUR][1000 genomes];0.98[ASN][1000 genomes]
rs10759698	0.95[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];1.00[YRI][hapmap];0.92[AMR][1000 genomes];0.93[EUR][1000 genomes];0.93[ASN][1000 genomes]
rs10759699	0.95[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];1.00[YRI][hapmap];0.90[EUR][1000 genomes];0.92[ASN][1000 genomes]
rs10817594	1.00[YRI][hapmap]
rs10817598	0.88[AMR][1000 genomes];0.99[EUR][1000 genomes];0.93[ASN][1000 genomes]
rs10817607	1.00[ASW][hapmap];0.95[CEU][hapmap];0.85[CHB][hapmap];0.80[CHD][hapmap];0.81[GIH][hapmap];0.95[JPT][hapmap];0.86[MEX][hapmap];0.96[TSI][hapmap];0.90[EUR][1000 genomes];0.81[ASN][1000 genomes]
rs10817609	0.90[EUR][1000 genomes]
rs10982192	0.87[CEU][hapmap];0.80[AMR][1000 genomes];0.80[EUR][1000 genomes]
rs10982193	0.95[CEU][hapmap];0.94[CHB][hapmap];0.95[JPT][hapmap];1.00[YRI][hapmap];0.94[AMR][1000 genomes];0.99[EUR][1000 genomes];0.93[ASN][1000 genomes]
rs10982201	0.94[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];1.00[YRI][hapmap];0.95[AMR][1000 genomes];0.99[EUR][1000 genomes];0.98[ASN][1000 genomes]
rs10982203	0.95[AMR][1000 genomes];0.99[EUR][1000 genomes];0.94[ASN][1000 genomes]
rs10982212	0.84[CHB][hapmap];0.95[JPT][hapmap]
rs10982213	0.95[CEU][hapmap];1.00[CHB][hapmap];0.90[CHD][hapmap];0.97[GIH][hapmap];1.00[JPT][hapmap];1.00[LWK][hapmap];0.86[MEX][hapmap];0.96[TSI][hapmap];0.89[EUR][1000 genomes];0.91[ASN][1000 genomes]
rs12002094	0.86[CEU][hapmap];0.87[JPT][hapmap];0.82[MEX][hapmap];0.96[TSI][hapmap];0.86[EUR][1000 genomes]
rs2274158	0.95[CEU][hapmap];1.00[CHB][hapmap];0.92[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];1.00[LWK][hapmap];1.00[MEX][hapmap];0.90[MKK][hapmap];1.00[TSI][hapmap];1.00[YRI][hapmap];0.95[AMR][1000 genomes];0.98[EUR][1000 genomes];0.98[ASN][1000 genomes]
rs2274161	0.85[CHB][hapmap];0.95[JPT][hapmap];0.90[EUR][1000 genomes];0.81[ASN][1000 genomes]
rs2274162	1.00[ASW][hapmap];0.95[CEU][hapmap];1.00[CHB][hapmap];0.92[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];1.00[LWK][hapmap];0.86[MEX][hapmap];0.81[MKK][hapmap];0.96[TSI][hapmap];0.90[EUR][1000 genomes];0.91[ASN][1000 genomes]
rs2274163	0.80[CHB][hapmap];0.95[JPT][hapmap]
rs3748174	0.85[CHB][hapmap];0.95[JPT][hapmap];0.89[EUR][1000 genomes];0.81[ASN][1000 genomes]
rs3748175	0.90[EUR][1000 genomes];0.81[ASN][1000 genomes]
rs4978584	0.95[CEU][hapmap];1.00[CHB][hapmap];0.90[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];1.00[LWK][hapmap];0.86[MEX][hapmap];0.96[TSI][hapmap];0.87[EUR][1000 genomes];0.90[ASN][1000 genomes]
rs4979375	0.95[CEU][hapmap];0.94[CHB][hapmap];0.97[CHD][hapmap];1.00[GIH][hapmap];0.95[JPT][hapmap];1.00[LWK][hapmap];1.00[MEX][hapmap];1.00[MKK][hapmap];0.96[TSI][hapmap];1.00[YRI][hapmap];0.97[AMR][1000 genomes];0.99[EUR][1000 genomes];0.98[ASN][1000 genomes]
rs4979378	1.00[ASW][hapmap];0.95[CEU][hapmap];1.00[CHB][hapmap];1.00[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];1.00[LWK][hapmap];1.00[MEX][hapmap];1.00[MKK][hapmap];1.00[TSI][hapmap];1.00[YRI][hapmap];0.95[AMR][1000 genomes];1.00[EUR][1000 genomes];0.98[ASN][1000 genomes]
rs4979379	0.95[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];1.00[YRI][hapmap];0.95[AMR][1000 genomes];0.98[EUR][1000 genomes];0.98[ASN][1000 genomes]
rs4979382	0.88[EUR][1000 genomes]
rs4979383	0.95[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];1.00[YRI][hapmap];0.90[EUR][1000 genomes];0.92[ASN][1000 genomes]
rs4979385	0.85[CHB][hapmap];0.86[JPT][hapmap]
rs4979386	0.95[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];1.00[YRI][hapmap];0.89[EUR][1000 genomes];0.91[ASN][1000 genomes]
rs7038862	1.00[ASW][hapmap];0.95[CEU][hapmap];1.00[CHB][hapmap];1.00[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];1.00[LWK][hapmap];1.00[MEX][hapmap];1.00[MKK][hapmap];1.00[TSI][hapmap];1.00[YRI][hapmap];0.95[AMR][1000 genomes];1.00[EUR][1000 genomes];0.98[ASN][1000 genomes]
rs7043417	0.95[AMR][1000 genomes];1.00[EUR][1000 genomes];0.97[ASN][1000 genomes]
rs731421	1.00[ASW][hapmap];0.95[CEU][hapmap];1.00[CHB][hapmap];0.90[CHD][hapmap];1.00[GIH][hapmap];0.95[JPT][hapmap];1.00[LWK][hapmap];0.86[MEX][hapmap];0.95[MKK][hapmap];0.96[TSI][hapmap];1.00[YRI][hapmap];0.91[EUR][1000 genomes];0.92[ASN][1000 genomes]
rs766835	0.95[AMR][1000 genomes];0.98[EUR][1000 genomes];0.98[ASN][1000 genomes]
rs7849013	0.95[CEU][hapmap];0.85[CHB][hapmap];0.95[JPT][hapmap];0.90[EUR][1000 genomes];0.81[ASN][1000 genomes]
rs7861409	0.85[CHB][hapmap];0.95[JPT][hapmap]
rs7864759	0.95[CEU][hapmap];0.85[CHB][hapmap];0.95[JPT][hapmap];0.90[EUR][1000 genomes];0.81[ASN][1000 genomes]
rs7875262	1.00[ASW][hapmap];0.95[CEU][hapmap];1.00[CHB][hapmap];0.90[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];1.00[LWK][hapmap];0.85[MEX][hapmap];1.00[MKK][hapmap];0.96[TSI][hapmap];1.00[YRI][hapmap];0.90[EUR][1000 genomes];0.92[ASN][1000 genomes]
rs7875632	0.90[EUR][1000 genomes];0.92[ASN][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:34 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv430093	chr9:116330446-117325446	Weak transcription Enhancers Strong transcription Flanking Active TSS Bivalent/Poised TSS Active TSS Genic enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	165 gene(s)	inside rSNPs	diseases
2	esv2422396	chr9:116792944-117354862	Weak transcription Enhancers Strong transcription Bivalent Enhancer Flanking Active TSS Genic enhancers Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	155 gene(s)	inside rSNPs	diseases
3	esv2422492	chr9:116811294-117366643	Genic enhancers ZNF genes & repeats Flanking Active TSS Weak transcription Strong transcription Enhancers Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	155 gene(s)	inside rSNPs	diseases
4	nsv466533	chr9:116930100-117248479	Enhancers Strong transcription Weak transcription Genic enhancers Flanking Active TSS Active TSS Transcr. at gene 5' and 3' ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA	128 gene(s)	inside rSNPs	diseases
5	nsv615233	chr9:116930100-117248479	Genic enhancers Weak transcription Enhancers Flanking Active TSS Strong transcription ZNF genes & repeats Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA	128 gene(s)	inside rSNPs	diseases
6	nsv1051544	chr9:116944940-117443031	ZNF genes & repeats Genic enhancers Weak transcription Enhancers Strong transcription Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	157 gene(s)	inside rSNPs	diseases
7	nsv540203	chr9:116944940-117443031	Enhancers Weak transcription Genic enhancers Active TSS Strong transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	157 gene(s)	inside rSNPs	diseases
8	nsv1048093	chr9:116945025-117456210	Active TSS Weak transcription Transcr. at gene 5' and 3' Enhancers Strong transcription Flanking Bivalent TSS/Enh Flanking Active TSS Genic enhancers Bivalent Enhancer ZNF genes & repeats Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	157 gene(s)	inside rSNPs	diseases
9	nsv1050991	chr9:116953739-117442999	Weak transcription Strong transcription Enhancers Genic enhancers Flanking Active TSS Transcr. at gene 5' and 3' Active TSS Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	157 gene(s)	inside rSNPs	diseases
10	nsv1046311	chr9:116953739-117447142	Genic enhancers Transcr. at gene 5' and 3' Enhancers Weak transcription Flanking Active TSS Strong transcription Active TSS Bivalent/Poised TSS ZNF genes & repeats Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	157 gene(s)	inside rSNPs	diseases
11	nsv1052877	chr9:116953739-117456210	Enhancers Flanking Active TSS Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS Active TSS ZNF genes & repeats Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	157 gene(s)	inside rSNPs	diseases
12	nsv1039681	chr9:116953739-117457158	Weak transcription Enhancers Flanking Active TSS Active TSS Genic enhancers Strong transcription Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	157 gene(s)	inside rSNPs	diseases
13	nsv1051987	chr9:116955841-117453668	Flanking Active TSS Strong transcription Active TSS Weak transcription Genic enhancers Enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	157 gene(s)	inside rSNPs	diseases
14	nsv1044374	chr9:116955841-117460150	Genic enhancers Active TSS Transcr. at gene 5' and 3' Enhancers Weak transcription Strong transcription Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	157 gene(s)	inside rSNPs	diseases
15	nsv466534	chr9:116956268-117455810	Weak transcription Enhancers Active TSS Strong transcription ZNF genes & repeats Flanking Active TSS Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	157 gene(s)	inside rSNPs	diseases
16	nsv615234	chr9:116956268-117455810	Enhancers Strong transcription Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh Genic enhancers Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	157 gene(s)	inside rSNPs	diseases
17	nsv1048817	chr9:116957958-117456210	Flanking Active TSS Weak transcription Enhancers Strong transcription Flanking Bivalent TSS/Enh Bivalent Enhancer ZNF genes & repeats Genic enhancers Transcr. at gene 5' and 3' Active TSS Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	157 gene(s)	inside rSNPs	diseases
18	nsv615235	chr9:116958144-117367061	ZNF genes & repeats Weak transcription Flanking Active TSS Genic enhancers Strong transcription Enhancers Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	148 gene(s)	inside rSNPs	diseases
19	nsv615236	chr9:116958144-117455810	Strong transcription Genic enhancers Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent/Poised TSS ZNF genes & repeats Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	157 gene(s)	inside rSNPs	diseases
20	nsv466535	chr9:116958144-117456175	Enhancers Genic enhancers Weak transcription Flanking Active TSS Active TSS Strong transcription Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	157 gene(s)	inside rSNPs	diseases
21	nsv615237	chr9:116958144-117456175	Strong transcription Active TSS Genic enhancers Enhancers Weak transcription Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer ZNF genes & repeats Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	157 gene(s)	inside rSNPs	diseases
22	nsv615238	chr9:116958144-117458475	Enhancers Weak transcription Strong transcription Flanking Active TSS Genic enhancers Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	157 gene(s)	inside rSNPs	diseases
23	nsv430094	chr9:116958446-117456446	Strong transcription Weak transcription Active TSS Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' Enhancers Bivalent Enhancer ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	157 gene(s)	inside rSNPs	diseases
24	nsv1053756	chr9:116975934-117443031	Enhancers Genic enhancers Weak transcription Strong transcription Bivalent Enhancer ZNF genes & repeats Flanking Active TSS Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	43 gene(s)	inside rSNPs	diseases
25	nsv540204	chr9:116975934-117443031	Genic enhancers Enhancers Active TSS Flanking Active TSS Weak transcription Strong transcription Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	43 gene(s)	inside rSNPs	diseases
26	nsv1047704	chr9:116978041-117399362	Weak transcription Active TSS ZNF genes & repeats Enhancers Flanking Active TSS Strong transcription Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	38 gene(s)	inside rSNPs	diseases
27	nsv540205	chr9:116978041-117399362	Enhancers Weak transcription Genic enhancers Flanking Active TSS Transcr. at gene 5' and 3' Strong transcription Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	38 gene(s)	inside rSNPs	diseases
28	nsv530950	chr9:117009156-117399361	Active TSS Weak transcription Enhancers Strong transcription Flanking Active TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Genic enhancers Bivalent/Poised TSS Bivalent Enhancer ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	37 gene(s)	inside rSNPs	diseases
29	nsv916139	chr9:117009169-117399454	Weak transcription Active TSS Strong transcription Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Genic enhancers ZNF genes & repeats Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	37 gene(s)	inside rSNPs	diseases
30	nsv1047822	chr9:117010663-117211517	Flanking Active TSS Enhancers Strong transcription Genic enhancers Weak transcription Transcr. at gene 5' and 3' ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA	13 gene(s)	inside rSNPs	diseases
31	nsv530951	chr9:117032675-117439804	Flanking Active TSS Weak transcription Genic enhancers Enhancers Active TSS Strong transcription Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent Enhancer ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	42 gene(s)	inside rSNPs	diseases
32	nsv1050256	chr9:117106276-117247033	Enhancers Flanking Active TSS Weak transcription Genic enhancers Strong transcription Transcr. at gene 5' and 3' Active TSS ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA	9 gene(s)	inside rSNPs	diseases
33	nsv540206	chr9:117106276-117247033	Flanking Active TSS Weak transcription Enhancers Strong transcription Genic enhancers Active TSS Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA	9 gene(s)	inside rSNPs	diseases
34	nsv831693	chr9:117116450-117281895	Weak transcription Strong transcription Enhancers Flanking Active TSS Active TSS Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA	15 gene(s)	inside rSNPs	diseases

mRNA abundance (count:3)

SNP	Gene	Cis/trans	Tissue	Source
rs10817602	SUSD1	cis	cerebellum	SCAN
rs10817602	PTPN3	cis	parietal	SCAN
rs10817602	C9orf80	cis	parietal	SCAN

Chromatin state (count:120 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:117159000-117161000	Active TSS	HSMMtube	muscle
2	chr9:117159400-117161200	Flanking Active TSS	Fetal Muscle Leg	muscle
3	chr9:117159600-117161000	Active TSS	Ovary	ovary
4	chr9:117159600-117161200	Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
5	chr9:117159600-117161200	Active TSS	Esophagus	oesophagus
6	chr9:117159600-117161200	Active TSS	Fetal Brain Female	brain
7	chr9:117159600-117161200	Active TSS	A549	lung
8	chr9:117159600-117161200	Active TSS	NHDF-Ad	bronchial
9	chr9:117159800-117161000	Active TSS	HUES6 Cell Line	embryonic stem cell
10	chr9:117159800-117161000	Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
11	chr9:117159800-117161200	Active TSS	ES-I3 Cell Line	embryonic stem cell
12	chr9:117159800-117161200	Active TSS	H9 Cell Line	embryonic stem cell
13	chr9:117159800-117161200	Active TSS	HUES48 Cell Line	embryonic stem cell
14	chr9:117159800-117161200	Active TSS	Foreskin Melanocyte Primary Cells skin01	Skin
15	chr9:117159800-117161200	Active TSS	Brain Germinal Matrix	brain
16	chr9:117159800-117161200	Active TSS	Fetal Kidney	kidney
17	chr9:117159800-117161200	Active TSS	Pancreatic Islets	Pancreatic Islet
18	chr9:117159800-117161200	Active TSS	Right Atrium	heart
19	chr9:117159800-117161200	Active TSS	HSMM	muscle
20	chr9:117160000-117161000	Active TSS	Primary monocytes fromperipheralblood	blood
21	chr9:117160000-117161000	Active TSS	Primary T helper memory cells from peripheral blood 2	blood
22	chr9:117160000-117161000	Active TSS	Brain Cingulate Gyrus	brain
23	chr9:117160000-117161000	Active TSS	Psoas Muscle	Psoas
24	chr9:117160000-117161000	Active TSS	Rectal Smooth Muscle	rectum
25	chr9:117160000-117161000	Active TSS	Skeletal Muscle Female	skeletal muscle
26	chr9:117160000-117161000	Active TSS	Stomach Mucosa	stomach
27	chr9:117160000-117161000	Active TSS	GM12878-XiMat	blood
28	chr9:117160000-117161000	Active TSS	Monocytes-CD14+_RO01746	blood
29	chr9:117160000-117161200	Active TSS	HUES64 Cell Line	embryonic stem cell
30	chr9:117160000-117161200	Active TSS	iPS-15b Cell Line	embryonic stem cell
31	chr9:117160000-117161200	Active TSS	iPS-18 Cell Line	embryonic stem cell
32	chr9:117160000-117161200	Active TSS	iPS-20b Cell Line	embryonic stem cell
33	chr9:117160000-117161200	Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
34	chr9:117160000-117161200	Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
35	chr9:117160000-117161200	Active TSS	Primary T killer memory cells from peripheral blood	blood
36	chr9:117160000-117161200	Active TSS	Brain Anterior Caudate	brain
37	chr9:117160000-117161200	Active TSS	Brain Substantia Nigra	brain
38	chr9:117160000-117161200	Active TSS	Fetal Lung	lung
39	chr9:117160000-117161200	Active TSS	Pancreas	Pancrea
40	chr9:117160000-117161200	Active TSS	K562	blood
41	chr9:117160000-117161200	Active TSS	NHLF	lung
42	chr9:117160000-117161200	Active TSS	Osteobl	bone
43	chr9:117160000-117161400	Active TSS	Breast Myoepithelial Primary Cells	Breast
44	chr9:117160200-117161000	Active TSS	H1 Cell Line	embryonic stem cell
45	chr9:117160200-117161000	Active TSS	IMR90 fetal lung fibroblasts Cell Line	lung
46	chr9:117160200-117161000	Active TSS	iPS DF 6.9 Cell Line	embryonic stem cell
47	chr9:117160200-117161000	Active TSS	Primary neutrophils fromperipheralblood	blood
48	chr9:117160200-117161000	Active TSS	Primary T helper cells PMA-I stimulated	--
49	chr9:117160200-117161000	Active TSS	Primary T cells effector/memory enriched fromperipheralblood	blood
50	chr9:117160200-117161000	Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links